Recent Advances in Targeted Drug Delivery Strategy for Enhancing Oncotherapy.

Li, Jianmin; Wang, Qingluo; Xia, Guoyu; Adilijiang, Nigela; Li, Ying; Hou, Zhenqing; Fan, Zhongxiong; Li, Jinyao

Li, Jianmin; Wang, Qingluo; Xia, Guoyu; Adilijiang, Nigela; Li, Ying; Hou, Zhenqing; Fan, Zhongxiong; Li, Jinyao.

Affiliation

Li J; College of Life Science and Technology & Institute of Materia Medica, Xinjiang University, Urumqi 830017, China.
Wang Q; College of Life Science and Technology & Institute of Materia Medica, Xinjiang University, Urumqi 830017, China.
Xia G; College of Life Science and Technology & Institute of Materia Medica, Xinjiang University, Urumqi 830017, China.
Adilijiang N; College of Life Science and Technology & Institute of Materia Medica, Xinjiang University, Urumqi 830017, China.
Li Y; Xiamen Key Laboratory of Traditional Chinese Bio-Engineering, Xiamen Medical College, Xiamen 361021, China.
Hou Z; College of Materials, Xiamen University, Xiamen 361002, China.
Fan Z; College of Life Science and Technology & Institute of Materia Medica, Xinjiang University, Urumqi 830017, China.
Li J; College of Life Science and Technology & Institute of Materia Medica, Xinjiang University, Urumqi 830017, China.

Pharmaceutics ; 15(9)2023 Aug 29.

Article de En | MEDLINE | ID: mdl-37765202

Mots clés

active targeting; nanocarriers; oncotherapy; passive targeting; targeted delivery

Texte intégral

Ajouter à My VHL

Imprimer

XML

PubMed Links

Recherche sur Google

Texte intégral: 1 Collection: 01-internacional Base de données: MEDLINE Langue: En Journal: Pharmaceutics Année: 2023 Type de document: Article Pays d'affiliation: Chine Pays de publication: Suisse

Texte intégral

Ajouter à My VHL

Imprimer

XML

PubMed Links

Recherche sur Google